SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,152.86 -417.49
( -0.55%)

Global Indices

Nasdaq

53,087.25 299.37
(0.57%)

Dow Jones

7,688.45 35.98
(0.47%)

Hang Seng

64,337.38 11.74
(0.02%)

Nikkei 225

10,761.93 -27.35
(-0.25%)

Forex

USD-INR

94.95 -0.29
(-0.30%)

EUR-INR

110.11 -0.38
(-0.35%)

GBP-INR

128.48 -0.52
(-0.40%)

JPY-INR

0.59 0.00
(-0.47%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Amerise Biosciences Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

531681

INE673C01020

0.8168581

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

5.22

EPS(TTM)

Face Value()

Div & Yield %

Back

Shukra Pharmaceuticals consolidated net profit rises 1158.25% in the June 2026 quarter

Aug 12,2026

Net profit of Shukra Pharmaceuticals rose 1158.25% to Rs 12.96 crore in the quarter ended June 2026 as against Rs 1.03 crore during the previous quarter ended June 2025. Sales rose 336.36% to Rs 23.52 crore in the quarter ended June 2026 as against Rs 5.39 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	23.52	5.39	336
OPM %	81.38	24.49	-
PBDT	19.25	2.16	791
PBT	18.17	1.37	1226
NP	12.96	1.03	1158

76,152.86 -417.49 ( -0.55%)

53,087.25 299.37 (0.57%)

7,688.45 35.98 (0.47%)

64,337.38 11.74 (0.02%)

10,761.93 -27.35 (-0.25%)

94.95 -0.29 (-0.30%)

110.11 -0.38 (-0.35%)

128.48 -0.52 (-0.40%)

0.59 0.00 (-0.47%)